JAK Inhibitor May Be as Effective as Biologics at Lower Cost: Prof. Takeuchi of Keio University

Speaking at a recent press seminar held by Pfizer Japan Inc. in Tokyo, Tsutomu Takeuchi, professor of Rheumatology, Department of Internal Medicine, Keio University, said that the novel rheumatoid arthritis treatment tofacitinib may be able to provide therapeutic benefits rivaling...read more